Russian corona virus vaccine has fewer side effects for fewer people in second phase trial
No side effects were seen in 85% of people receiving the Russian vaccine against the Sputnik V corona virus. Alexander Gintzberg, head of the Gamalaya research center, which built it, gave information about it on Monday. Alexander said: “Side effects from the vaccine were seen in 15% of people.” The third phase of the Sputnik V trials is underway.
The doubt of the western media
Russia registered its first vaccine against the corona virus Sputnik V in August. Many questions have been raised around the world, especially in the West. Western countries had alleged that Russia was in a hurry just to move forward in the vaccine race. In fact, Russia had registered the vaccine without completing the third phase of the trial. At the same time, Russia had said it had developed the vaccine using its old technology and therefore developed rapidly.
Dimitrov interviewed Western media. He asked why the media is silent on the dangers of trying to produce a vaccine based on a chimpanzee adenovirus vector. The company previously said that the results of the Russian vaccine trial showed that the human adenovirus vector could be superior to mRNA or the chimpanzee adenovirus vector.
This is how vaccines are made
This two-part vaccine comprises recombinant human adenovirus type 26 (RAD26-S) and recombinant human adenovirus type 5 (RAD5-S). According to researchers, “adenovirus” usually causes a cold. It has also been weakened in vaccines so that they cannot replicate in human cells and cause disease.
Good news in the battle with Corona, this happened for the first time after March 22